{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:29:33Z","timestamp":1767907773040,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","award":["2012ZX10002001"],"award-info":[{"award-number":["2012ZX10002001"]}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Construction ProjectofCharacteristic Key Disciplines for Universities of Shanxi Province"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.034","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T13:04:50Z","timestamp":1490274290000},"page":"2443-2448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial"],"prefix":"10.1016","volume":"35","author":[{"given":"Jing","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.034_b0005","unstructured":"WHO: Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. In: Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence, Geneva; 2009."},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.034_b0010","doi-asserted-by":"crossref","first-page":"e005997","DOI":"10.1136\/bmjopen-2014-005997","article-title":"Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis","volume":"5","author":"Sun","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2017.03.034_b0015","article-title":"The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review","volume":"2","author":"Karki","year":"2016","journal-title":"Evid Based Med Public Health"},{"issue":"7","key":"10.1016\/j.vaccine.2017.03.034_b0020","doi-asserted-by":"crossref","first-page":"e68906","DOI":"10.1371\/journal.pone.0068906","article-title":"Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2017.03.034_b0025","first-page":"879","article-title":"Evaluation on the long-term effectiveness among the first set eight methadone maintenance treatment clinics in China","volume":"33","author":"Cao","year":"2012","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2017.03.034_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-10-23","article-title":"Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China \u2013 a prospective study","volume":"10","author":"Chen","year":"2013","journal-title":"Harm Reduct J"},{"issue":"12","key":"10.1016\/j.vaccine.2017.03.034_b0035","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/OLQ.0b013e318272c497","article-title":"Unprotected sex among HIV-positive treatment-seeking opioid-dependent adults in China: a cross-sectional study","volume":"39","author":"Zhang","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2017.03.034_b0040","doi-asserted-by":"crossref","first-page":"e76931","DOI":"10.1371\/journal.pone.0076931","article-title":"High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.034_b0045","first-page":"57","article-title":"Prevalence and network-characteristics of risky sexual behaviors among clients receiving methadone maintenance treatment at clinics in Taizhou prefecture of Zhejiang province","volume":"36","author":"Bai","year":"2015","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2017.03.034_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.drugalcdep.2014.09.776","article-title":"Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study","volume":"145","author":"Cao","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1136","key":"10.1016\/j.vaccine.2017.03.034_b0055","first-page":"324","article-title":"Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination","volume":"114","author":"Carter","year":"2001","journal-title":"N Z Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.034_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.psychres.2014.12.053","article-title":"Inflammatory response in heroin addicts undergoing methadone maintenance treatment","volume":"226","author":"Chan","year":"2015","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.034_b0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0376-8716(84)90051-6","article-title":"Immunological status in heroin addicts: effects of methadone maintenance treatment","volume":"13","author":"Lazzarin","year":"1984","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.034_b0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.vaccine.2017.03.034_b0075","unstructured":"WHO. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization; 2015."},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.034_b0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1360-0443.2009.02765.x","article-title":"The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic","volume":"105","author":"Ramasamy","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.034_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1360-0443.1999.9444894.x","article-title":"Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination","volume":"94","author":"Borg","year":"1999","journal-title":"Addiction"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.03.034_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-4453(83)96603-3","article-title":"Immune response to hepatitis B vaccine in drug addicts","volume":"7","author":"Schalm","year":"1983","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.034_b0095","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/10550887.2014.969623","article-title":"Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions","volume":"33","author":"Perlman","year":"2014","journal-title":"J Addict Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.034_b0100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.vaccine.2016.01.018","article-title":"Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China","volume":"34","author":"Wang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.034_b0105","unstructured":"CFDA. The standard guidelines for adverse reactions grading of vaccine clinical trials. China Food and Drug Administration."},{"issue":"11","key":"10.1016\/j.vaccine.2017.03.034_b0110","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1080\/21645515.2015.1055424","article-title":"Hepatitis B and A vaccination in HIV-infected adults: A review","volume":"11","author":"Mena","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2017.03.034_b0115","doi-asserted-by":"crossref","first-page":"e80409","DOI":"10.1371\/journal.pone.0080409","article-title":"Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial","volume":"8","author":"Chaiklang","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.034_b0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1360-0443.2002.00147.x","article-title":"Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response","volume":"97","author":"Quaglio","year":"2002","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.vaccine.2017.03.034_b0125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0264-410X(92)90516-M","article-title":"Immune response to hepatitis B vaccine in parenteral drug abusers","volume":"10","author":"Rodrigo","year":"1992","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.034_b0130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archinte.1991.00400030110020","article-title":"Suboptimal response to hepatitis B vaccine in drug users","volume":"151","author":"Rumi","year":"1991","journal-title":"Arch Intern Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T22:37:42Z","timestamp":1655678262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303407"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}